High-resolution FLAIR MRI at 7 Tesla for treatment planning in glioblastoma patients.


Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
01 2019
Historique:
received: 28 05 2018
revised: 10 07 2018
accepted: 17 08 2018
pubmed: 5 9 2018
medline: 18 12 2019
entrez: 5 9 2018
Statut: ppublish

Résumé

Ultra-high field MRI is an emerging technique promising high-resolution images for radiotherapy planning. We compared a 7 Tesla FLAIR sequence with clinical FLAIR imaging at 3 Tesla in glioblastoma patients before radiotherapy. High-resolution 7 Tesla FLAIR imaging may enhance the depiction of organs at risk and possibly modify target volumes.

Identifiants

pubmed: 30177373
pii: S0167-8140(18)33440-6
doi: 10.1016/j.radonc.2018.08.002
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

180-184

Informations de copyright

Copyright © 2018 The Author(s). Published by Elsevier B.V. All rights reserved.

Auteurs

Sebastian Regnery (S)

Department of Radiation Oncology, Heidelberg University Hospital, Germany; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Benjamin R Knowles (BR)

Division of Medical Physics in Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Daniel Paech (D)

Division of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Nicolas Behl (N)

Division of Medical Physics in Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Jan-Eric Meissner (JE)

Division of Medical Physics in Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Paul Windisch (P)

Department of Radiation Oncology, Heidelberg University Hospital, Germany.

Semi Ben Harrabi (S)

Department of Radiation Oncology, Heidelberg University Hospital, Germany; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center (HIT), Im Neuenheimer Feld 450, 69120 Heidelberg, Germany.

Denise Bernhardt (D)

Department of Radiation Oncology, Heidelberg University Hospital, Germany; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Heinz-Peter Schlemmer (HP)

Division of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Mark E Ladd (ME)

Division of Medical Physics in Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Physics and Astronomy and Faculty of Medicine, University of Heidelberg, Germany.

Stefan Rieken (S)

Department of Radiation Oncology, Heidelberg University Hospital, Germany; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Jürgen Debus (J)

Department of Radiation Oncology, Heidelberg University Hospital, Germany; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center (HIT), Im Neuenheimer Feld 450, 69120 Heidelberg, Germany.

Sebastian Adeberg (S)

Department of Radiation Oncology, Heidelberg University Hospital, Germany; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center (HIT), Im Neuenheimer Feld 450, 69120 Heidelberg, Germany. Electronic address: sebastian.adeberg@med.uni-heidelberg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH